ARTMS Products Inc. Raises US$3 Million to Advance a Safe Alternative Way to Locally Produce Medical Isotopes and Avoid Future Supply Distruptions

Vancouver, British Columbia. – December 18, 2017 – Today, ARTMS Products Inc., the leader in the development of novel technologies which enable the production of the world’s most-used diagnostic imaging isotope, announced it has raised US$3 million.  The investment comes from Quark Venture Inc. and GF Securities, through their Global Health Science Fund, which invests […]

ARTMS Products Inc. and GE Healthcare Team up to Expand Cyclotron Produced Radioisotopes and Address Longstanding Radiopharmaceutical Supply Concerns in Medical Imaging

Today, ARTMS Products, Inc. announced they have signed a strategic partnership with GE Healthcare around ARTMS’ proprietary QUANTM99TM Irradiation System (QISTM) for radioisotope production. The goal of the partnership is to supply equipment, technologies and research that supports the production and processing of radioisotopes on GE’s PETtraceTM 800 platform of medical cyclotrons. The QISTM integrates […]

ARTMS Products Inc. Honoured with ‘Most Promising Pre-Commercial Technology’ Award at BC Technology Impact Awards

ARTMS Products, Inc., a Vancouver-based medical technology company, has won ‘Most Promising Pre-Commercial Technology’ at the BC Tech Technology Impact Awards recently held in Vancouver. Chosen from a very competitive pool of companies from diverse areas of industry, this distinction is granted to the company poised to drive fundamental change in their industry within the […]